These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7497605)

  • 1. Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigen.
    Heston WD
    Clin Chem; 1995 Dec; 41(12 Pt 1):1687-8. PubMed ID: 7497605
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen.
    Loric S; Dumas F; Eschwege P; Blanchet P; Benoit G; Jardin A; Lacour B
    Clin Chem; 1995 Dec; 41(12 Pt 1):1698-704. PubMed ID: 7497608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of flow cytometry and RT-PCR in the detection of circulating PSA-positive cells in prostate cancer.
    Fadlon EJ; Hamdy FC
    Methods Mol Biol; 1998; 92():215-25. PubMed ID: 9664517
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.
    Israeli RS; Miller WH; Su SL; Samadi DS; Powell CT; Heston WD; Wise GJ; Fair WR
    J Urol; 1995 Mar; 153(3 Pt 1):573-7. PubMed ID: 7532229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.
    Moreno JG; O'Hara SM; Long JP; Veltri RW; Ning X; Alexander AA; Gomella LG
    Urology; 1997 Apr; 49(4):515-20. PubMed ID: 9111619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The PSA gene: value in detection of circulating prostate cancer cells].
    de la Taille A; Colombel M; Amsellem S; Muscatelli B; Radvanyi F; Mazeman E; Abbou CC; Chopin D
    Prog Urol; 1997 Dec; 7(6):930-6. PubMed ID: 9490137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumor cells in men with localized prostate cancer.
    Seiden MV; Kantoff PW; Krithivas K; Propert K; Bryant M; Haltom E; Gaynes L; Kaplan I; Bubley G; DeWolf W
    J Clin Oncol; 1994 Dec; 12(12):2634-9. PubMed ID: 7527455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
    Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
    Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostate-specific membrane antigen. A new sensitive molecular indicator in metastasizing prostatic cancer].
    Kippersund JT; Haukeland B; Lilleeng BF; Daehlin L; Haukaas S; Høisaeter PA; Ogreid D
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3612-5. PubMed ID: 8539714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
    Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
    Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular staging of hematogenous microdissemination of prostate cancer cells].
    Kunimi K
    Hinyokika Kiyo; 1996 Oct; 42(10):791-4. PubMed ID: 8951477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Berteau P; Dumas F; Loric S; Eschwège P; Gala JL
    J Urol; 1998 May; 159(5):1649-50. PubMed ID: 9554383
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.
    de Cremoux P; Ravery V; Podgorniak MP; Chevillard S; Toublanc M; Thiounn N; Tatoud R; Delmas V; Calvo T; Boccon-Gibod L
    Eur Urol; 1997; 32(1):69-74. PubMed ID: 9266235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of PSA mRNA and PSMA mRNA by RT-PCR].
    Deguchi T; Ehara H; Takahashi Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():151-5. PubMed ID: 12599562
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.
    Fadlon EJ; Rees RC; McIntyre C; Sharrard RM; Lawry J; Hamdy FC
    Br J Cancer; 1996 Aug; 74(3):400-5. PubMed ID: 8695355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2.
    Kawakami M; Okaneya T; Furihata K; Nishizawa O; Katsuyama T
    Cancer Res; 1997 Oct; 57(19):4167-70. PubMed ID: 9331068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients.
    Straub B; Müller M; Krause H; Schrader M; Miller K
    Oncology; 2003; 65 Suppl 1():12-7. PubMed ID: 12949428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.